Product Information
ONGLYZA 5 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $15.5149 per EA under NDC 00310610590. Its NADAC has been published 560 times since Jan 28, 2015.
The High Outlier badge above means this manufacturer's average price in the SAXAGLIPTIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310610590
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022350On Market Since
11/20/2014
Pharmacological Classes
Price Statistics
The NADAC for ONGLYZA 5 MG TABLET has been published 560 times since Jan 28, 2015, and over the history we have for it it has risen 47.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.5149 per EA |
|---|---|
| All-time high | $15.5173 (Oct 11, 2023) |
| All-time low | $10.4590 (Apr 22, 2015) |
| 52-week high | $15.5149 |
| 52-week low | $15.5149 |
| Median price | $13.8427 |
| Average price | $13.7345 |
| Largest weekly change | +11.8% (Dec 9, 2015) |
| Weeks tracked | 560 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ONGLYZA 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONGLYZA 5 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $15.5149 per EA (NDC 00310610590), effective Oct 15, 2025.
How has the price of ONGLYZA 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONGLYZA 5 MG TABLET has risen 47.9%. It has been tracked across 560 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for ONGLYZA 5 MG TABLET?
Since Jan 28, 2015, the NADAC for ONGLYZA 5 MG TABLET has ranged from a low of $10.4590 (Apr 22, 2015) to a high of $15.5173 (Oct 11, 2023), with a median of $13.8427 per EA.
Are there cheaper alternatives to ONGLYZA 5 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SAXAGLIPTIN HCL 5 MG TABLET, is $1.1176 per EA — about 93% below ONGLYZA 5 MG TABLET.
Who manufactures ONGLYZA 5 MG TABLET?
ONGLYZA 5 MG TABLET (NDC 00310610590) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification